Mironid
Mironid is a biopharmaceutical company developing novel small-molecule therapeutics that target cAMP degrading phosphodiesterase enzymes. The company specifically focuses on treating Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases by addressing the central signaling mechanisms that drive these conditions. Their pipeline aims to provide differentiated therapies for patients with high unmet clinical needs, including those at risk of kidney failure.
Biotechnology
Pharmaceuticals
Healthtech
Funding summary
- Total raised
- €6.0M
- Funding rounds
- 1
Investors in Mironid
Investors on record for Mironid. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Mironid?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors